+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics in Australia

  • PDF Icon

    Report

  • 27 Pages
  • November 2022
  • Region: Australia
  • Euromonitor International
  • ID: 228392
Value sales of analgesics continue to rise in Australia in 2022 following a particularly strong performance the previous year when demand was partly driven by the ongoing effects of the pandemic and stockpiling tendencies.

The Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market
  • Pinpoint growth sectors and identify factors driving change
  • Understand the competitive environment, the market’s major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

ANALGESICS IN AUSTRALIA

KEY DATA FINDINGS

2022 DEVELOPMENTS
  • Rise in common colds and illnesses post-pandemic leads to further demand for analgesics in Australia
  • Panic buying continues to place pressure on supply chain of analgesics
  • Reckitt Benckiser (Australia) Pty Ltd launches next generation of Nurofen with Nurofen Meltlets
PROSPECTS AND OPPORTUNITIES
  • Growth rates to gradually normalise over forecast period but demand will remain high despite rising unit prices
  • Associated harmful side effects could trigger more conservative use of analgesics
  • Chronic pain expected to rise over the forecast period contributing to sales of analgesics
CATEGORY DATA
  • Table 1 Sales of Analgesics by Category: Value 2017-2022
  • Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
  • Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
  • Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
  • Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
  • Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN AUSTRALIA

EXECUTIVE SUMMARY
  • Consumer health in 2022: The big picture
  • 2022 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
  • Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2017-2022
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
  • Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
  • Summary 1 OTC: Switches 2021-2022
DISCLAIMER

DEFINITIONS

SOURCES
  • Summary 2 Research Sources